Unknown PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT01175928

Pneumatic Medicine: A Transformative Treatment for Diabetic Peripheral Neuropathy

Phase 2 Study of the NormaTec PCD in the Treatment of Diabetic Peripheral Neuropathy

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Interventions NormaTec PCD (Peristaltic Pulse PCD) Sham device

Updated 6 times since 2017 Last updated: Apr 18, 2012 Started: Oct 31, 2010 Primary completion: Sep 30, 2012 Completion: Sep 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Diabetic Polyneuropathy and is currently ongoing. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1_PHASE2
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE1_PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE1_PHASE2

First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NormaTec Industries LP

Data source: NormaTec Industries LP

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Newton Center, United States